Risultati della ricerca - Keith Johnson
- Mostra 1 - 4 risultati su 4
-
1
Plasma Phosphorylated Tau181 as a Biomarker for Alzheimer's Disease Co‐Pathology in Lewy Body Disease Autoría: Rong Ye, Pia Kivisäkk, Anna Goodheart, Hadia Fatima, Erin Peterec, Emma Thibault, Michael Properzi, Keith Johnson, Steven Arnold, Stephen N. Gomperts
Pubblicazione 2025Fuente: Wiley Open AccessTipo de material: Artículo Open AccessAcceso al recurso -
2
Long‐term safety and efficacy of lecanemab in early Alzheimer's disease: Results from the clarity AD open‐label extension study Autoría: Christopher H. van Dyck, Reisa Sperling, Keith Johnson, Shobha Dhadda, Michio Kanekiyo, David Li, Michelle Gee, Steven Hersch, Michael Irizarry, Lynn Kramer
Pubblicazione 2025Fuente: Wiley Open AccessTipo de material: Artículo Open AccessAcceso al recurso -
3
Considerations in the clinical use of amyloid PET and CSF biomarkers for Alzheimer's disease Autoría: Antoine Leuzy, Ariane Bollack, Daniela Pellegrino, Charlotte E. Teunissen, Renaud La Joie, Gil D. Rabinovici, Nicolai Franzmeier, Keith Johnson, Frederik Barkhof, Leslie M. Shaw, Alexander Arkhipenko, Suzanne E. Schindler, Lawrence S. Honig, Alexis Moscoso Rial, Michael Schöll, Henrik Zetterberg, Kaj Blennow, Oskar Hansson, Gill Farrar
Pubblicazione 2025Fuente: Wiley Open AccessTipo de material: Artículo Open AccessAcceso al recurso -
4
Racial and ethnic differences in plasma biomarker eligibility for a preclinical Alzheimer's disease trial Autoría: Doris Patricia Molina‐Henry, Rema Raman, Andy Liu, Oliver Langford, Keith Johnson, Leona K. Shum, Crystal M. Glover, Shobha Dhadda, Michael Irizarry, Gustavo Jimenez‐Maggiora, Joel B. Braunstein, Kevin Yarasheski, Venky Venkatesh, Tim West, Philip B. Verghese, Robert A. Rissman, Paul Aisen, Joshua D. Grill, Reisa A. Sperling
Pubblicazione 2024Fuente: Wiley Open AccessTipo de material: Artículo Open AccessAcceso al recurso